Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Merieux Equity Partners phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
The financing will enable the company to advance its lead candidate to the clinic and to build a pipeline of next-generation antibody-drug conjugates (ADCs)Its proprietary ADC technology opens the door
Press release content from Business Wire. The AP news staff was not involved in its creation.
AcuSurgical raises €5.75 Million in Series A financing, to advance its robotic ocular microsurgery platform.
February 18, 2021 GMT
MONTPELLIER, France (BUSINESS WIRE) Feb 18, 2021
AcuSurgical, a Montpellier-based company focused on robotic microsurgery, today announces a €5.75 million Series A financing round led by Mérieux Equity Partners (via OMX Europe Venture Fund) and Supernova Invest (via Supernova 2 Fund), with Sofimac Innovation (via Pertinence Invest 2 Fund) and IRDI Capital Investissement (via Irdinov 2 and Inn’Vest PME Occitanie Est Funds) participating in the round.
ADVERTISEMENT
Using advanced robotics, AcuSurgical is making ocular microsurgery safer and more accessible by dramatically improving the precision of surgical interventions. A proof of concept of the platform has already been completed with a first prototype validated in a preclinical setting.